Fluorescence imaging of tumor sections revealed that eGFP+/FoxP3+ Tregs accounted for about 50% of the total number of immune cells in the tumor mass and peritumor space on days 9 and 16 (Figure 5 (a)). This evidence concerns the gene FOXP3 and neoplasm.